Bluejay Diagnostics Announces Completion of Prefunded Warrant Exercises

Bluejay Diagnostics has announced that all prefunded warrants issued in its October 2025 private placement have been exercised, with approximately 972,000 shares of common stock outstanding. The company also has cash exercisable warrants for around 1.5 million shares, with a minimum cash exercise price of $7.00 per share. Recent Schedule 13G filings may not reflect the 1-for-4 reverse stock split that occurred on January 29, 2026.